Colin Ernest Dawson

Photonic Innovations Ltd. supplies gas detection products. Its products include gas sensing devices that monitor and detect environments which could contain combustible gases, toxic gases and to ensure sufficient oxygen availability. The firm serves oil and gas, mining, utilities, hospitality and civil engineering industries. The company was founded in 2005 and is headquartered in Dunedin, New Zealand.

HSAGlobal Ltd. designs and develops healthcare software. Its services include manage acute demand, support early discharge, deliver complex care in the community, promote medications adherence, co-ordinate service delivery, and support patient self-management. The company was founded by Matthew John Hector Taylor on December 21, 2008 and is headquartered in Auckland, New Zealand.

Part of Techion Holdings Ltd., Menixis Ltd. develops products for small particle microscopy. The company is based in Dunedin, New Zealand.

Avalia Immunotherapies Ltd. develops immunotherapies that support the treatment of cancer. The company is headquartered in Lower Hutt, New Zealand.

CertusBio Ltd. develops biosensor technologies for industrial and environmental monitoring. The company was founded by Ralph Henry Wattinger and John Denholm Patterson on April 21, 2015 and is headquartered in Lincoln, New Zealand.

Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand.

Mars Bioimaging Ltd. operates as a manufacturer of small bore spectral computerized tomography scanners for pre-clinical medical research. It products include scanners, detectors and visualization machines. The company was founded by Philip Howard Butler and Anthony Philip Howard Butler in 2007 and is headquartered in Christchurch, New Zealand.

Tiro Medical Ltd. engages in the development of tools for digital medicine sector. It commercializes its technologies including a zero pain, zero radiation breast cancer screening system; and digital decision support tool for ICU to reduce risk, length of stay and patient costs. The company was founded on March 20, 2014 and is headquartered in Christchurch, New Zealand.